Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Short Interest Down

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Get Rating) saw a significant decrease in short interest during the month of September. As of September 15th, there was short interest totalling 2,300,000 shares, a decrease of 12.9% from the August 31st total of 2,640,000 shares. Based on an average trading volume of 471,500 shares, the short-interest ratio is […]

Related Keywords

, Morgan Stanley , Atea Pharmaceuticals Trading , Goldman Sachs Group Inc , Nasdaq , News Ratings For Atea Pharmaceuticals Daily , Atea Pharmaceuticals , Atea Pharmaceuticals Inc , Hermes Inc , Group Plc , Institutional Trading Of Atea Pharmaceuticals , Get Rating , General Group Plc , Point Capital Management , Sachs Group , Wexford Capital , Atea Pharmaceuticals Daily , Nasdaq Avir , Tavir , Medical , Stocks , Options , Put , Call ,